8-K: SCYNEXIS Receives Nasdaq Delisting Warning Due to Sub-$1.00 Share Price

SCYNEXis, Inc. has received a notice from Nasdaq regarding its non-compliance with the minimum bid price rule, initiating a 180-day period to regain compliance.

Summary

• SCYNEXIS, Inc. received a letter from Nasdaq on June 20, 2025, notifying the company of non-compliance with the minimum bid price rule.
• The company's common stock closing bid price has been below the required $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1).
• This notice does not immediately affect the listing of SCYNEXIS's common stock on the Nasdaq Global Market.
• SCYNEXIS has 180 calendar days from June 20, 2025, until December 17, 2025 (the Compliance Date), to regain compliance.
• Compliance can be regained if the closing bid price is at least $1.00 per share for a minimum of 10 consecutive business days.
• If compliance is not regained by the Compliance Date, SCYNEXIS may be eligible to transfer to the Nasdaq Capital Market for an additional 180-day compliance period, provided it meets other listing requirements and intends to cure the deficiency, potentially via a reverse stock split.
• Failure to regain compliance could lead to delisting, though the company can appeal the decision to a Nasdaq Hearings Panel.

Sentiment

Score: 3

Explanation: The document conveys a negative sentiment due to the Nasdaq non-compliance notice and the potential for delisting. While there's a compliance period, the underlying issue of a sustained low stock price is concerning, and there's no guarantee of resolution.

Positives

• The notice has no immediate effect on the listing of SCYNEXIS's common stock on the Nasdaq Global Market.
• SCYNEXIS has a 180-day grace period, until December 17, 2025, to regain compliance with the minimum bid price rule.
• The company may be eligible for an additional 180-day compliance period if it transfers to the Nasdaq Capital Market, offering more time to resolve the issue.

Negatives

• SCYNEXIS's common stock has traded below the $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1).
• Failure to regain compliance by December 17, 2025, could lead to a transfer to the Nasdaq Capital Market or, ultimately, delisting from Nasdaq.
• There is no assurance that SCYNEXIS will be able to regain compliance with the minimum bid price rule or will otherwise be in compliance with other Nasdaq listing rules.

Risks

• Risk of delisting from the Nasdaq Global Market if the minimum bid price requirement is not met by the Compliance Date.
• Risk of not qualifying for an additional compliance period on the Nasdaq Capital Market.
• Risk that an appeal to the Nasdaq Hearings Panel, if a delisting notice is received, would not be successful.
• Risk that a reverse stock split, if implemented, may not be effective in curing the deficiency or could have other negative impacts on shareholder value.
• General risk of not being able to comply with other Nasdaq listing rules, beyond the minimum bid price.

Future Outlook

SCYNEXIS will continue to actively monitor the closing bid price of its common stock and evaluate available options to resolve the deficiency and regain compliance with the Nasdaq minimum bid price rule. The company may consider a reverse stock split if necessary to meet the $1.00 per share requirement.

Management Comments

• "SCYNEXIS will continue to actively monitor the closing bid price of its common stock and will evaluate available options to resolve the deficiency and regain compliance with the minimum bid price rule."

Industry Context

This type of delisting notice for failing to meet minimum bid price requirements is common for smaller, often pre-revenue or early-stage companies, particularly in sectors that may experience significant stock price volatility or prolonged periods of low valuation. It highlights the ongoing challenge for such companies to maintain exchange listing standards amidst market pressures and investor sentiment.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, which could reduce liquidity and investor confidence. Potential for further stock price decline if compliance is not regained or if a reverse stock split is implemented.
• Employees: Potential impact on employee morale and retention due to uncertainty regarding the company's listing status and future.
• Company Operations: Maintaining Nasdaq listing is crucial for access to capital markets and corporate visibility, which could be hampered if delisted.

Next Steps

• SCYNEXIS must achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days by December 17, 2025.
• If compliance is not met by the Compliance Date, SCYNEXIS may seek to transfer to the Nasdaq Capital Market and apply for an additional 180-day compliance period.
• SCYNEXIS will continue to monitor its stock price and evaluate options, including a potential reverse stock split, to regain compliance.
• If a delisting notice is received, SCYNEXIS may appeal the Staff's determination to a Nasdaq Hearings Panel.

Key Dates

Recommendation

Keywords

SCYNEXIS, SCYX, Nasdaq, Delisting Notice, Minimum Bid Price, Listing Compliance, Stock Market, 8-K Filing, Corporate Governance